Anebulo Pharmaceuticals, Inc. (ANEB) vs BioCardia, Inc. (BCDA)
Anebulo Pharmaceuticals, Inc. and BioCardia, Inc. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and BioCardia, Inc. are of similar size ($17.6M and $16.2M). Across the 8 metrics below, Anebulo Pharmaceuticals, Inc. leads on 6 and BioCardia, Inc. on 2.
Valuation
Profitability
| Metric | ANEB | BCDA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (69.69%) | (1,803.19%) | (57.72%) |
| Return on assets | (63.17%) | (214.47%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack